References
1. European Association for the Study of the Liver Electronic address easloffice@easlofficeeu; Clinical practice guidelines panel; Wendon J; Panel Members; Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017 May; 66(5): 1047- 81[Links]
2. Breu AC, Patwardhan VR, Nayor J, Ringwala JN, Devore ZG, Ganatra RB, et al. A multicenter study into causes of severe acute liver injury. Clin Gastroenterol Hepatol. 2019 May; 17(6): 1201-3.[Links]
3. Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014 Apr; 383(9927): 1503-16.[Links]
4. Aricò M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis: review. Br J Haematol. 2001 Sep; 114(4): 761-9.[Links]
5. Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematology. 2015 Dec 5; 2015(1):177-82.[Links]
6. Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine. 2014 Mar; 93(2): 100-5.[Links]
7. Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis: hemophagocytic lymphohistiocytosis of Adults. Am J Hematol. 2015 Mar; 90(3): 220-4.[Links]
8. Eichhorst B, Robak T, Montserrat E, Ghia P, Niemann CU, Kater AP, et al. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Jan; 32(1): 23-33.[Links]
9. Kilari D, Venci N, Friedberg J, Bennett JM. Hemophagocytic lymphohistiocytosis masquerading as progressive chronic lymphocytic leukemia. Leuk Res Rep. 2013; 2(1): 4-6.[Links]
10. Vlachonikola E, Stamatopoulos K, Chatzidimitriou A. T cells in chronic lymphocytic leukemia: a two-edged sword. Front Immunol. 2020; 11: 612244.[Links]
11. Riches JC, Ramsay AG, Gribben JG. T-cell function in chronic lymphocytic leukaemia. Semin Cancer Biol. 2010 Dec; 20(6): 431-8.[Links]
12. Yahya AM, Al-Hammadi S, AlHashaykeh NO, Alkaabi SS, Elomami AS, AlMulla AA, et al. Case report: reactive lymphohistiocytic proliferation in infant with a novel nonsense variant of IL2RG who received BCG vaccine. Front Pediatr. 2021 Nov 2; 9: 713924.[Links]
13. Ikebe T, Takata H, Sasaki H, Miyazaki Y, Ohtsuka E, Saburi Y, et al. Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation. Int J Hematol. 2017 Apr; 105(4): 389-91.[Links]
14. Lagousi T, Korovessi P, Panagouli E, Tsagris V, Kostaridou S. A rare case of measles-associated hemophagocytic lymphohistiocytosis in an infant. Cureus. 2020 May 23; 12(5): e8246.[Links]
15. Ai S, Awford A, Roncolato F. Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination. J Med Virol. 2022 Jan; 94(1): 14-6.[Links]
16. Attwell L, Zaw T, McCormick J, Marks J, Mc-Carthy H. Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination. J Clin Pathol. 2022; 75(4): 282-4.[Links]
17. Tang LV, Hu Y. Hemophagocytic lymphohistiocytosis after COVID-19 vaccination. J Hematol Oncol. 2021 Dec; 14(1): 87.[Links]
18. Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 Jun 10; 384(23): 2202-11.[Links]
19. Lin S, Li Y, Long J, Liu Q, Yang F, He Y. Acute liver failure caused by hemophagocytic lymphohistiocytosis in adults: a case report and review of the literature. Medicine. 2016 Nov; 95(47): e5431.[Links]
20. Favara BE. Histopathology of the liver in histiocytosis syndromes. Pediatr Pathol Lab Med. 1996 Jan; 16(3): 413-33.[Links]
21. Chen JH, Fleming MD, Pinkus GS, Pinkus JL, Nichols KE, Mo JQ, et al. Pathology of the liver in familial hemophagocytic lymphohistiocytosis. Am J Surg Pathol. 2010 Jun; 34(6): 852-67.[Links]
22. Tseng YT, Sheng WH, Lin BH, Lin CW, Wang JT, Chen YC, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011 Jun; 44(3): 191-7.[Links]
23. La Rosée P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019 Jun 6; 133(23): 2465-77.[Links]
24. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome: score for reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep; 66(9): 2613-20.[Links]
25. Kim YR, Kim DY. Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults. Blood Res. 2021 Apr 30; 56(S1): S17-25[Links]
